 |
|
 |
AIDS in China - 1
Mother-to-Infant HIV Transmission: Its Status, Crisis
and Countermeasures
By: Cao Yunzhen and Li
Guanhan of the Laboratory of Clinical Virology of the
Center for AIDS Prevention and Control, the Ministry
of Health, Beijing 100050; Wang Shiyi of Kunming
Station for Disease Control; Cheng Hehe of Yunnan
Station for Pubic Health and Disease Control; Sun
Feng of Yili Station for Public Health and Disease
Control, Xinjiang; Zhou Zengquan of Kunming Hospital
of Infectious Diseases; and He Yun of the Sixth
People's Hospital in Zhengzhou:
Shanghai
Zhonghua Chuanranbing Zazhi Vol. 20 No 3 in
Chinese 15 Jun 02 pp 185-188
1. Situation of Mother-to-Infant Transmission of
HIV 1 Worldwide
HIV/AIDS has become a major cause of death for
children around the world. In 90 percent of the
cases, HIV is transmitted from mother to child. It
was estimated that 2,400,000 HIV-infected women gave
birth, creating 600,000 HIV-infected babies every
year. Everyday, 1600 newborns are infected with HIV.
In Africa, infant mortality rose by 75 percent and
child mortality increased by 100 percent because of
HIV infection. In Uganda, 34 percent of its
HIV-infected children died before reaching the age of
one, 66 percent died before three, and 75 percent
died before five. HIV/AIDS has created more than 11
million orphans who lost both parents. HIV is
primarily a sexually-transmitted disease. Developing
nations are most vulnerable to its threat. In Africa,
HIV has been running rampant for quite some time. In
many areas, more than 20 percent of the pregnant
women have been infected already. Most children were
infected during birth or breast feeding. Very few
were infected in the uterus. The HIV-1 transmission
rate in the perinatal period is 20 to 42 percent [1].
In developing nations breast feeding is an important
risk factor in the vertical transmission of HIV-1.
The infection rate is substantially higher in
developing nations than that in industrialized
countries.
In recent years, it is possible to block
mother-to-infant HIV transmission by drugs,
especially in western industrialized nations. With
long-term use of AZT and formula feeding, the
mother-to-infant HIV-1 transmission rate has fallen
to less than 5 percent. Since 1992, clinical trials
began in the United States and France according to
Protocol PACTG 076. AZT was given starting from 14 to
32 weeks of pregnancy. The drug was administered
intravenously during childbirth. The newborn was also
given the drug for six weeks. This protocol lowered
the mother-to-infant HIV transmission rate by 67
percent [2]. Afterward, a short-term AZT protocol was
also found to be successful [3]. In a recent joint
study carried out by Uganda and the United States, a
few units of nevirapine (NVP) was given to pregnant
women during labor and to newborns less than three
days old. This protocol was found to have reduced
perinatal HIV-1 transmission rate by 47 percent.
(This is equivalent to the effect of the short-term
of AZT.) According to a cost estimate made by a drug
manufacturer, the entire protocol costs less $4 [4].
This is great news for developing nations.
2. Female HIV-Infected Patients in China
Among adults in China, HIV-1 is primarily transmitted
through intravenous (IV) injection of illicit drugs,
unprotected sex, and illegal blood trade. Let us take
Yunnan as an example. Between 1989 and 1994, HIV-1
infection was confined to IV drug users in the
southwestern border. It began to spread across the
province in 1995. Between 1986 and the end of 1998, a
total of 580,036 people were put under surveillance,
and 5,604 were found to be HIV-1 positive. Among
these people, there were 854 females. They
represented approximately 15 percent of the total. As
for the vehicle of infection, 65 percent came from
needle-sharing, and 23 percent from sexual
transmission [5]. The Guangxi Zhuang Autonomous
Region in southwestern China is an area widely open
to the outside world. Since AIDS monitoring began in
1986 until 1995, only 10 cases of HIV-1 positive
patients were found. They were either foreigners or
people from outside the region. However, since the
first discovery of HIV-1 infected patients among drug
addicts in western Guangxi in April 1996, the rate of
transmission has accelerated noticeably. By the end
of 1999, a cumulative total of 1175 HIV-1 positive
cases were discovered, and 16.1 percent of them were
females. This figure is higher than those in other
provinces in China. Among the HIV-positive patients,
76 percent were infected were IV drug users. In this
category, 20.8 percent were women. This is the
highest percentage in China. In addition, these IV
drug users sexually transmitted the virus to their
spouses and partners. Most of these female IV drug
users had multiple sex partners or were engaged in
prostitution.
Prostitution is on the rise from cities to the
countryside. Venereal diseases, eradicated in the
1960s and 1970s, are spreading across China at an
unbelievably high speed. The total number of venereal
disease cases across the country reached 358,324 in
2000. Compared to 1997, it increased by 87.53
percent. It is 28.5 times of that in 1987, as shown
in Table 1. The rapid rise of commercial sexual
behavior and venereal diseases not only negatively
impacts the physical and mental health of young
women, but also helps the transmission of HIV.
According to surveys of customers of prostitutes done
in Yunnan, no HIV infected patient was found between
1995 and 1997. In 1998, the HIV infection rate was
0.3 percent. In 1999, it went up to 1.1 percent,
which represented a 266.7 percent increase over one
year. Among the prostitutes, there was no HIV
infected person between 1992 and 1994. In 1995, the
HIV infection rate was 0.5 percent. In 1999, it went
up to 2.2 percent. At this rate of increase, it was
estimated that the infection rate would reach 5.4
percent in 2003 [6].
Table 1 Female Venereal Disease Cases in China
Between 1977 and 2000
|
Year
|
Cases |
|
1977
1982
1987
1992
1997
1998
1999
2000
|
1
160
12,562
75,371
191,068
286,112
350,620
258,324 |
3. Status of Mother-to-Infant HIV Transmission in
China
In 1992, there were two monitoring stations for
pregnant women in Yunnan, and they were confined to
the Dehong area. It grew to five in 1996. By 1998, it
increased to 10, covering nine different areas, as
shown in Table 2. The number of women and their
spouses infected with HIV is rising. In 1999, the
average HIV-1 infection rate for pregnant women was
0.2 percent (see Table 3). The first case of
mother-to-infant transmission of HIV-1 in Yunnan was
reported in 1995. To date, a total of 46 HIV-1
positive pregnant women have been discovered. Among
the 52 newborns, 15 were infected with the HIV-1
virus (out of 42 children tested), as shown in Table
4. A rough estimate based on figures such as
population, birth rate, and mean HIV infection rate
for 1998 and 1999, at least 1500 pregnant women and
500 newborns were infected by the HIV virus annually
[5, 6]. In Xinjiang, IV drug users account for 97
percent of its HIV infected population. Women
represent 8 percent of the total. The first case of
mother-to-infant transmission was reported in 1996.
The baby died in 17 months [7, 8]. In 1999, 1200
pregnant women visiting OB/GYN clinics and admitted
to hospitals were tested in Wulumuqi, and six of them
were found to be HIV-1 positive. The rate of
infection was 0.5 percent. In five cases, the virus
was sexually transmitted. The remaining case was due
to a tainted blood transfusion [9]. Between 1997 and
1999, a total of 22 HIV-1 positive pregnant women
were found at monitoring sites and hospitals in Yili.
This is on top of the six cases discovered in
Wulumuqi. In most cases, the outcome of the newborns
was not known. In 1998, three children from Anhui and
Guangdong were tested positive for the HIV-1 antibody
according to international adoption agencies, as
shown in Table 5. Although additional rigorous tests
eliminated the possibility of HIV-1 infection, it is
obvious that their mothers were infected with the
HIV-1 virus.
Table 2 Number of Monitoring Sites Detecting HIV-1
Positive Pregnant Women in Yunnan Between 1992 and
1999
| |
1992 |
1993 |
1994 |
1995 |
1996 |
1997 |
1998 |
1999 |
| Number of
Monitoring Sites |
2 |
4 |
5 |
5 |
5 |
8 |
10 |
10 |
| Number of
Sites Detected HIV Infection |
1 |
1 |
1 |
2 |
2 |
3 |
6 |
8 |
Table 3 HIV-1 Spousal Infection Rate and Pregnant
Women Infection in Yunnan
| Year |
Wives of IV
Drug Users ( percent) |
Pregnant
Women ( percent) |
1986 - 1988
1990
1991
1992
1993
1994
1997
1999 |
ND
2/53 (3.8)
0/7 (0)
5/100 (5)
7/146 (4.8)
3/48 (6.25)
11/83 (13.3) |
ND
ND
1/492 (0.2)
0/1234 (0)
1/2387 (0.04)
4/3567 (0.11)
0 - 0.6 (average 0.1)
0 - 1.6 (average 0.2) |
Table 4 Distribution of Mother-to-Infant HIV-1
Transmission Cases in Certain Areas of China
| Area |
HIV(+)
Pregnant Women |
- |
Infant
HIV/AIDS Status |
- |
- |
| - |
- |
HIV(+) |
HIV(-) |
Unknown |
Total |
Yunnan
Guangdong
Guangxi
Fujian
Zhejiang
Anhui
Shanghai
Hubei
Henan
Hebei
Shanxi
Beijing
Liaoning
Xingjiang |
46
8
2
1
1
2
2
1
15
2
1
2
2
17 |
15
1
0
1
1
1
2
1
6
1
1
0
0
4 |
28
4
1
0
0
0
0
0
8
1
0
2
2
8 |
9
3
2
0
0
1
0
0
2
0
0
0
0
7 |
52
8
3
1
1
2
2
1
16
2
1
2
2
19 |
| Total |
102 |
34 |
54 |
24 |
112 |
Table 5 Detection of HIV-1 Serum Antibody in Three
Adopted Chinese Children
| Province |
Test Date |
Age (months) |
Birth Date |
ELISA
Antibody |
W.B. |
PBMC PCR |
Anhui
Guangdong
Anhui |
6/98
5/29/98
6/20/98 |
16
12
17 |
2/10/97
6/10/97
2/10/97 |
Positive (+)
Positive (+)
Positive (+) |
Negative (-)
Suspicious
Negative (-) |
Negative (-)
Negative (-)
Negative (-) |
As of the end of 2000, there were only 23 cases of
mother-to-infant HIV-2 transmission in China. Neither
a retrospective nor a prospective study has been
conducted even in high HIV infection rate areas. In
addition, diagnostic equipment necessary to determine
HIV infection in babies (less than 18 months old) is
essentially not available locally. Hence, we do not
have a precise picture on the status of
mother-to-infant HIV-1 transmission and its rate of
propagation. Based on the data collected by various
local health and disease control organizations, we
are not optimistic about the situation. Out of the
112 newborns (53 males, 52 females, and 7 unknowns)
borne by 102 HIV-1 positive pregnant women, 34 were
found to be HIV-1 positive, 54 were negative (4
blocked by NVP during birth), 2 were suspicious, and
22 were untested or waiting to be tested. 38.6
percent of the children (34/88) were HIV positive. As
for the method of delivery, 50 delivered naturally,
11 gave birth by Caesarian section, 3 were induced,
and 45 were unknown. The percentage of breast feeding
was 80 percent (36/45). By region, Yunnan, Xinjiang,
Henan, and Guangdong are the leaders, as shown in
Table 4. However, there is no significance with
regard to epidemiology. Based on the total number of
HIV infected people reported, Guangxi and Sichuan
should be the leaders. However, among the cases shown
here, there were very few cases from these two areas.
Of course, this is related to whether the local
authority has begun this line of work. In addition,
HIV-1 infection in Henan was brought under the
limelight because of its illegal blood trade. Tests
showed that 98 percent of the plasma and blood
samples taken from some illegal blood trading
stations in Henan were HIV-1 positive [10]. However,
the status of HIV infection in the region is still
unclear.
In conclusion, the status of mother-to-infant HIV
infection in China may be far worse than people
imagine today. As the HIV/AIDS situation deteriorates
in China, the number of mother-to-infant HIV
transmission cases will also rise. Chinese children
are under serious threat by HIV/AIDS.
4. Measures To Block Mother-to-Infant HIV
Transmission
In the Second Conference on Global Strategies for the
Prevention of HIV Transmission from Mothers to
Infants held in Montreal, Canada in September 1999,
it was pointed out that the HIV epidemic had reached
an alarming scale. Were it allowed to propagate at
the present rate, its threat will exceed the sum of
all other health problems combined. According to the
WHO, without any intervention, there will be 5 to 10
million HIV infected children in the world in the
next 10 years, and 90 percent of them will be in
Africa and Asia. To this end, the Conference sent an
emergency plea to the world to "prevent HIV
transmission from mothers to infants." Various
governments, non-governmental organizations, and
pharmaceutical companies were urged to donate to this
cause, and to implement effective measures to block
perinatal transmission of the HIV virus.
Mother-to-infant HIV transmission may take place in
the uterus, during the perinatal period, or through
breast feeding. However, there are many other factors
determining whether this mother-to-infant
transmission occurs, including the mother's disease
stage, virological characteristics, immunological
state, placenta factors (such as physical damage or
inflammation), genetic factors (such as polymorphism
of ancillary receptor), and obstetric factors (such
as method of delivery) [11-16]. The placenta may
become more "permeable" due to infection by another
pathogen to increase the probability of
mother-to-infant transmission of the HIV virus. Many
studies showed that the virus level in the mother was
closely related to the mother-to-infant transmission
of the HIV-1 virus. However, there is not a clear
critical value between transmission and no
transmission. The factors related to the fetus or
infant, such as CTL response and polymorphism of the
HIV ancillary receptor, may also have some influence.
The method of delivery has an important effect on
mother-to-infant transmission of the disease.
Caesarian section can shorten and minimize the
contact between the baby and vaginal secretion and
maternal blood, which can drastically reduce the rate
of occurrence. In addition, washing the vagina and
giving supplemental nutrients to pregnant women (such
as Vitamin A) can also decrease the rate of
mother-to-infant transmission. In conclusion, various
mutually interacting factors are determining whether
the HIV virus will be transmitted from a mother to
her infant. Hence, we should pay attention to all
possible factors. There is a need to conduct
additional studies.
To block HIV transmission, based on its propagation
mechanism and influencing factors, the most effective
available measures are as follows: drug blockade,
formula feeding, and Caesarian section. In China, HIV
is primarily affecting minorities at the border and
rural areas in middle of the country. Due to factors
such as poverty, low culture standard, and shame, it
is extremely difficult to promote Caesarian section.
Specific local situation must be taken into account
to decide whether formula feeding should be promoted.
In Asia, the rate of mother-to-infant transmission is
approximately 30 percent. Only 1/3 of the cases were
infected by mother's milk. Breast feeding has many
advantages. Whether to unilaterally promote formula
feeding must be carefully considered. It is best to
explain the advantages and disadvantages of breast
feeding to the patient, and allow the patient to make
her own decision. Heating the milk before feeding is
another viable approach. Of course, measures such as
vaginal washing and vitamin supplement are also very
important. They should be adopted whenever possible.
Using an anti-reverse-transcription drug as an
intervening treatment is the most effective measure
to block mother-to-infant transmission of the HIV-1
virus. Taking AZT following a standard protocol is
very effective against mother-to-infant transmission.
A short-term protocol is also effective. However, it
is not suited for remote and rural areas due to its
high cost and complicated protocol. In these areas,
we should promote the use of a single dose of NVP [4,
17]. We used NVP to treat four HIV-1 positive
pregnant women in Kunming and Dalian, and followed up
for 5 to 9 months to date. Serum specimens of the
four infants showed negative HIV RNA, as shown in
Table 6. Of course, it is better to use the standard
AZT protocol in cities and developed areas along the
coast. We may even be better off using the AZT + 3TC
protocol. Based on the latest report, the latter
could lower the mother-to-infant transmission rate to
1.6 percent.
Table 6 HIV-1 Positive Pregnant Women and Their
Children Using NVP as the Blocking Agent
| Number |
Birth Date |
Path |
Delivery
Method |
Delivery
Date |
- |
- |
- |
- |
- |
| |
|
|
|
|
Number |
Sex |
Feeding |
HIV-1 RNA |
Spouse Status |
YN08M
YN08M
YN33M
DL02M |
06/75
09/78
03/68
04/73 |
Sexually
IVDC
Unknown
Sexually |
Natural
Caesarian
Caesarian
Natural |
09/12/00
08/25/00
09/30/00
12/14/00 |
YN08C
YN20C
YN33C
DL02C |
F
M
F
M |
Formula
Formula
Formula
Formula |
Negative
Negative
Negative
Negative |
HIV1(+)(IVDU)
Unknown
Muslin, HIV1(-)
HIV1(+) |
From the overall standpoint, the fundamental approach
to preventing HIV transmission from mothers to
infants is to control HIV infection in China.
However, various levels of government still need to
formulate and implement a series of effective
countermeasures to prevent young women who are either
already HIV-infected or become HIV-infected from
transmitting the disease to the next generation. We
believe that we have to launch an effective campaign
to increase people's awareness of HIV related issues,
including methods to prevent mother-to-infant
transmission. Next, we have to seek the funding
necessary to establish a foundation to pay for NVP
treatment. Drugs should be free in remote and poor
areas for old and young patients. Third, we must
expand urine HIV screening in OB/GYN clinics and
during pre-marital examinations. This reagent is
already available in China. It will be manufactured
domestically in the near future. It is a low cost and
convenient method, and can easily be accepted by
patients [19].
References
[1] Li Guanhan and Yu Dongmei, Information on the
Second International Strategic Workshop on
Mother-to-Infant HIV Transmission, Zhongguo Redai
Yixue [China Tropical Medicine], Vol 1, 2001 pp 83 -
85.
[2] Connor EM, Speling RS, Gelber R, et al.,
Reduction of Maternal-Infant Transmission of Human
Immunodeficiency Virus Type l with Zidovudine
Treatment, N. Eng. J. Med., Vol 331, 1994 pp 1173 -
1180.
[3] Fiscus SA, Schoenbach VJ, and Wilfert C, Short
Courses of Zidovudine and Perinatal Transmission of
HIV, N. Eng. J. Med., Vol 340, 1999 pp 1040 - 1041.
[4] Guay LA, Musoke P, Fleming T, et al., Intrapartum
and Neonatal Single Dose Nevirapine Compared with
Zidovudine for Prevention of Mother-to-Child
Transmission of HIV-1 in Kampala, Uganda: HIVNET 012
Randomized Trial, Lancet, Vol 354, 1999 pp 795 - 802.
[5] Pan Songfeng, Cheng Hehe, Zhang Jiapeng, et al.,
1996 HIV Surveillance Report in Yunnan, Zhongguo
Xingbing Aizibing Fangzhi [Control of Venereal
Diseases and AIDS in China], Vol 3, 1997 pp 244 -
246.
[6] Cheng Hehe Zhang Jiapeng, Pan Songfeng, et al.,
Trend Analysis and Forecast of HIV Transmission in
Yunnan, Zhongguo Xingbing Aizibing Fangzhi [Control
of Venereal Diseases and AIDS in China], Vol 6, 2000
pp 257 - 260.
[7] Sun Fengm Dilixiati Sha, Nayila A, et al., First
Case Report of Maternal HIV Transmission in Xinjiang,
Zhongguo Xingbing Aizibing Fangzhi [Control of
Venereal Diseases and AIDS in China], Vol 3, 1997 p
248.
[8] Lin Xuedong, Sun Feng, Pan Pingliang, et al.,
Identification of a Typical AIDS Family in China and
Analysis of the Sequence of the env Gene of the
Virus, Bingdu Xuebao [Chinese Journal of Virology],
Vol 15, 1999 pp 7 - 13.
[9] Zhou Mei, Peng Hong, Zhang Zhongyuan, et al.,
Analysis of HIV Antibody Surveillance Data on 1200
Pregnant Women in Wulumuqi, Zhongguo Xingbing
Aizibing Fangzhi [Control of Venereal Diseases and
AIDS in China], Vol 6, 2000 pp 290 - 291.
[10] Li Shengwang and Sun Guijun, Analysis of Blood
Quality at Underground Blood Stores, Zhongguo
Xingbing Aizibing Fangzhi [Control of Venereal
Diseases and AIDS in China], Vol 6, 2000 pp 12 - 13.
[11] Jin X, Roberts CG, Nixon DF, et al.,
Longitudinal and Cross-Sectional Analysis of
Cytotoxic T Lymphocyte Responses and Their
Relationship to Vertical Human Immunodeficiency Virus
Transmission, ARIEL Project Investigators, J. Infect.
Dis., Vol 178, 1998 pp 1317 - 1326.
[12] Zhang Y, Dragic T, Cao T, et al., Use of
Corecepors Other Than CCR5 by Non-Syncytium-Inducing
Adult and Pediatric Isolates of Human
Immunodeficiency Virus Type 1 Is Rare in vitro, J.
Virol., Vol 72 pp 1998 pp 9337 - 9344.
[13] Kuhn L, Steketee RW, Weedon J, et al., The
Perinatal AIDS Collaborative Transmission Study -
Distinct Risk Factors for Intrauterine and
Intrapartum Human Immunodeficiency Virus Transmission
and Consequences for Disease Propagation in Infected
Children, J. Infect. Dis., Vol 179, 1999 pp 52 - 58.
[14] Van de Perre P, Transmission of Human
Immunodeficiency Virus Type 1 Through Breast-Feeding:
How Can It Be Prevented?, J. Infect. Dis., Vol 179 (Suppl.
3), 1999 pp S405- S407.
[15] Van Tine BA, Shaw GM and Aldrovanti G,
Mother-to-Infant Transmission of the Human
Immunodeficiency Virus During Primary Infection, N.
Eng. J. Med., Vol 341, 1999 p 1548.
[16] Shaffer N, Roongpisuthipong A, Siriwasin W, et
al., Maternal Virus Load and Perinatal Human
Immunodeficiency Virus Type 1 Subtype E Transmission,
Thailand Bangkok Collaborative Perinatal HIV
Transmission Study Group, J. Infect. Dis., Vol 179,
1999 pp 590 - 599.
[17] Heltzer NE, Perinatal Screening, Infants and
Zidovudine, Post-Exposure Prophylaxis, Adverse Events
with Nevirapine, The AIDS Reader, Vol 11, 2001 pp 81
- 82.
[18] Mandelbrot L, Landreau Mascaro A, Rekacewicz C,
et al., Lamivudine-Zidovudine Combination for
Prevention of Maternal-Infant Transmission of HIV 1,
JAMA, Vol 285, 2001 pp 2083 - 2093.
[19] Lun Wenhuai, Li Li, Huang Qin, et al., Analysis
of Detection of HIV-1 Antibody in Urine Specimens
from HIV Infected Patients by ELISA, Zhongguo
Xingbing Aizibing Fangzhi [Control of Venereal
Diseases and AIDS in China], Vol 7, 2001 pp 32 - 34.
MS received 02 Dec 2001.
Editor: Li Xin
Affiliations of Authors: Cao Yunzhen and Li Guanhan
are from the Laboratory of Clinical Virology of the
Center for AIDS Prevention and Control, the Ministry
of Health, Beijing 100050; Wang Shiyi is at the
Kunming Station for Disease Control; Cheng Hehe is at
the Yunnan Station for Pubic Health and Disease
Control; Sun Feng works at the Yili Station for
Public Health and Disease Control, Xinjiang; Zhou
Zengquan works at the Kunming Hospital of Infectious
Diseases; and He Yun is at the Sixth People's
Hospital in Zhengzhou.
[Description of Source: Shanghai Zhonghua
Chuanranbing Zazhi in Chinese -- quarterly journal of
the Shanghai Branch of the Chinese Medical
Association]
[FBIS Translated Text]
© 2003 China AIDS Survey Monterey, California
|